An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine

• Claire Wu,

  Affiliation Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Jessica Yuen,

  Affiliation Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Heidi N. Boyda,

  Affiliation Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Ric M. Procyshyn,

  Affiliations Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada, British Columbia Mental Health and Addictions Research Institute, Vancouver, British Columbia, Canada

  ⨯
• Cathy K. Wang,

  Affiliation Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Yahya I. Asiri,

  Affiliation Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Catherine C. Y. Pang,

  Affiliation Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• William G. Honer,

  Affiliations Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada, British Columbia Mental Health and Addictions Research Institute, Vancouver, British Columbia, Canada

  ⨯
• Alasdair M. Barr

  * E-mail: albarr@interchange.ubc.ca

  Affiliations Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada, British Columbia Mental Health and Addictions Research Institute, Vancouver, British Columbia, Canada

  ⨯